Aehr Test Systems' CEO Discusses Q2 2012 Results - Earnings Call Transcript

Aehr Test Systems (AEHR)

Q2 2012 Earnings Call

January 05, 2012 5:00 pm ET


Gary L. Larson - Chief Financial Officer, Principal Accounting Officer and Vice President of Finance

Gayn Erickson -

Rhea J. Posedel - Founder, Chairman and Chief Executive Officer

Marilynn Meek -


Geoffrey Scott



Good day, ladies and gentlemen, and thank you for standing by. Welcome to the Aehr Test Systems Second Quarter Fiscal 2012 Earnings Conference Call. [Operator Instructions] This conference call is being recorded today, Thursday, January 5 of 2012. And I'd now like to turn the conference over to Ms. Marilynn Meek. Please go ahead, ma'am.

Marilynn Meek

Thank you. Good afternoon, and thanks for joining us to discuss Aehr Test Systems' second quarter fiscal 2012 results. By now, you should have all received a copy of today's press release. If not, you can call my office at (212) 827-3746, and we'll get one to you right away.

With us today from Aehr Test Systems are Rhea Posedel, Executive Chairman; Gayn Erickson, Chief Executive Officer; and Gary Larson, Vice President of Finance and Chief Financial Officer. Management will review its operating performance for the quarter before opening the call to your questions. I'd now like to turn the call over to Gary Larson. Please go ahead, Gary.

Gary L. Larson

Thank you, Marilynn, and thanks to everyone for joining us today. Before we begin, I'd like to make a few comments about forward-looking statements. Please be advised that during the course of our discussion today, we may make forward-looking statements that involve risks and uncertainties relating to projections regarding industry growth and customer demand for Aehr Test products, as well as projections regarding Aehr Test's future financial performance. Actual results may differ materially from projected results and should not be considered as an indication of future performance. These risks and uncertainties include, without limitation, world economic conditions, the state of the semiconductor equipment market, acceptance by customers of Aehr Test technologies, acceptance by customers of the systems shipped upon receipt of a purchase order, the ability of new products to meet customer needs or perform as described, the company's ability to maintain sufficient cash to support operations, the company's marketing of a commercially successful wafer-level test and burn-in system and the potential emergence of alternative technologies, each of which could adversely affect demand for Aehr Test products in calendar year 2012. We refer you to our most recent 10-K, 10-Q and other reports from time to time filed with the U.S. Securities and Exchange Commission for a more detailed description of the risks facing our business and factors that could cause actual results to differ materially from projected results.

The company disclaims any obligation to update information contained in any forward-looking statements to reflect events or circumstances occurring after the date of this conference call. Now I'd like to introduce our Executive Chairman, Rhea Posedel. Rhea?

Rhea J. Posedel

Thank you, Gary. Good afternoon, and welcome to our conference call for the second quarter of fiscal year 2012. Let me begin by saying I'm pleased to announce that on Tuesday, Gayn Erickson was appointed CEO of Aehr Test. I'm in excellent health and was planning to work until I was 70, but with the acquisition of Verigy by Advantest last year, Gayn became available. We are fortunate to have hired a senior executive with 23 years of semiconductor, test and general management experience. With Gayn's strong marketing and engineering background from a top-tier test company, we are confident that he will do an outstanding job and has the management skill set needed to take Aehr Test to the next level. I will remain with the company as Executive Chairman and will work with Gayn on strategic plans to grow the company.

Since Gayn just started this week, I will be giving today's conference call. Gayn will, however, say a few words at the conclusion of my talk.

On a positive note, net sales for the quarter were $3.9 million, 8% higher compared to the second quarter of fiscal 2011. We had several highlights that I'd like to bring to your attention. First, we are very pleased to report that our valuation ABTS-L56i burn-in system passed its qualification at a leading IDM. Most importantly, we expect to receive an order to record revenue for this evaluation system this quarter. This would be a major win for us because it's a production account, and we believe this customer could order significant number of ABTS-L56i systems over the long term. Their target application is for burn-in of high-power logic devices requiring individual temperature control per device.

Second. Last month, we report -- announced selling a high-power ABTS burn-in system with individual device temperature control to one of the world's largest IC manufacturers. Their target application is for reliability testing and qualification of 2x nanometer technology, including mobile and tablet processors. This is another major win for our ABTS product family, and we hope to see follow-on orders after the delivery and acceptance of the first system.

Third, we shipped 3 additional ABTS burn-in systems to a leading Japanese microcontroller producer, and we expect to receive a follow-on order from their Singapore production site this quarter. This customer is a production account for us, and we believe they will purchase higher quantities of systems as their capacity ramps in the second half of calendar 2012.

Fourth, we designed and have shipped the first article of 4 new FOX-15 WaferPak cartridge designs to a leading automotive provider of magnetic sensors. This is important because we hope to see follow-on orders for production quantities of WaferPaks as their sensors are qualified by automobile manufacturers later this calendar year.

Read the rest of this transcript for free on

More from Stocks

Stocks Are Lower as Dow Heads for Eighth Straight Drop

Stocks Are Lower as Dow Heads for Eighth Straight Drop

Novo Nordisk Stock Pops Nearly 3% on Positive Diabetes-Drug Results

Novo Nordisk Stock Pops Nearly 3% on Positive Diabetes-Drug Results

Video: Here's Why One Markets Pro Is Raising Cash Right Now

Video: Here's Why One Markets Pro Is Raising Cash Right Now

Why Spotify Is the Ultimate Speculative Stock to Buy

Why Spotify Is the Ultimate Speculative Stock to Buy

Mesoblast Soars on Stem-Cell Treatment Data

Mesoblast Soars on Stem-Cell Treatment Data